Joseph Pitts actually said...

"I think it is irresponsible for us to stand by and expect FDA to cobble together a piecemeal approach to regulating the practice of compounding pharmacy."

"Isn't that correct?"

"Is it important to preserve the States' ability to license and enforce national standards?"

"And finally, would a National track-and-trace standard increase the efficacy of product recalls?"